Literature DB >> 29443507

Three-Dimensional Directionality Is a Pivotal Structural Feature for the Bioactivity of Azabisphosphonate-Capped Poly(PhosphorHydrazone) Nanodrug Dendrimers.

Myriam Hayder1, Matteo Garzoni2, Davide Bochicchio2, Anne-Marie Caminade3,4, François Couderc5, Varravaddheay Ong-Meang5, Jean-Luc Davignon1, Cédric-Olivier Turrin3,4, Giovanni M Pavan2, Rémy Poupot1.   

Abstract

Dendrimers are nanosized, nonlinear, hyperbranched polymers whose overall 3D shape is key for their biological activity. Poly(PhosphorHydrazone) (PPH) dendrimers capped with aza-bisphosphonate (ABP) end groups are known to have anti-inflammatory properties enabling the control of inflammatory diseases in different mouse models. Here we screen the anti-inflammatory activity of a series of PPH dendrimers bearing between 2 and 16 ABP end groups in a mouse model of arthritis and confront the biological results with atomistic simulations of the dendrimers. We show that only the PPH dendrimers capped with 10 and 12 ABP end groups can control the flare of the inflammatory disease. All-atom accelerated molecular dynamics simulations show that dendrimers with a low number of ABP end groups are directional but highly flexible/dynamic and have thereby limited efficiency in establishing multivalent interactions. The largest dendrimer appears as nondirectional, having 16 ABP end groups forming patches all over the dendrimer surface. Conversely, intermediate dendrimers having 10 or 12 ABP end groups reach the best compromise between the number of surface groups and their stable directional gathering, a real maximization of multivalency.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29443507     DOI: 10.1021/acs.biomac.7b01398

Source DB:  PubMed          Journal:  Biomacromolecules        ISSN: 1525-7797            Impact factor:   6.988


  7 in total

Review 1.  Biomedical nanomaterials for immunological applications: ongoing research and clinical trials.

Authors:  Vincent Lenders; Xanthippi Koutsoumpou; Ara Sargsian; Bella B Manshian
Journal:  Nanoscale Adv       Date:  2020-08-24

2.  An Anti-Inflammatory Poly(PhosphorHydrazone) Dendrimer Capped with AzaBisPhosphonate Groups to Treat Psoriasis.

Authors:  Ranime Jebbawi; Abdelouahd Oukhrib; Emily Clement; Muriel Blanzat; Cédric-Olivier Turrin; Anne-Marie Caminade; Eric Lacoste; Séverine Fruchon; Rémy Poupot
Journal:  Biomolecules       Date:  2020-06-23

Review 3.  The ABP Dendrimer, a Drug-Candidate against Inflammatory Diseases That Triggers the Activation of Interleukin-10 Producing Immune Cells.

Authors:  Séverine Fruchon; Rémy Poupot
Journal:  Molecules       Date:  2018-05-25       Impact factor: 4.411

4.  Biodistribution and Biosafety of a Poly(Phosphorhydrazone) Dendrimer, an Anti-Inflammatory Drug-Candidate.

Authors:  Séverine Fruchon; Elisabeth Bellard; Nicolas Beton; Cécile Goursat; Abdelouahd Oukhrib; Anne-Marie Caminade; Muriel Blanzat; Cédric-Olivier Turrin; Muriel Golzio; Rémy Poupot
Journal:  Biomolecules       Date:  2019-09-11

Review 5.  Repolarization of Unbalanced Macrophages: Unmet Medical Need in Chronic Inflammation and Cancer.

Authors:  Yannick Degboé; Rémy Poupot; Mary Poupot
Journal:  Int J Mol Sci       Date:  2022-01-28       Impact factor: 5.923

Review 6.  AB5 Derivatives of Cyclotriphosphazene for the Synthesis of Dendrons and Their Applications.

Authors:  Artem Zibarov; Abdelouahd Oukhrib; Julien Aujard Catot; Cédric-Olivier Turrin; Anne-Marie Caminade
Journal:  Molecules       Date:  2021-06-30       Impact factor: 4.411

Review 7.  Multivalent nanosystems: targeting monocytes/macrophages.

Authors:  Rémy Poupot; Cécile Goursat; Séverine Fruchon
Journal:  Int J Nanomedicine       Date:  2018-09-19
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.